sdr glomerular

Upload: allie-ally

Post on 02-Jun-2018

235 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/10/2019 sdr glomerular

    1/44

    1

    GLOMERULAR SYNDROMES

    LIGIA PETRESCU

  • 8/10/2019 sdr glomerular

    2/44

    2

    BACKGROUND

    This class of kidney disease centers around theglomerulus.This is where the main filtration of thenephron occurs and is located within theBowman's capsule.

    It is comprised of a mass of tiny tubes throughwhich the blood passes.Its semipermeable structure allows water andsoluble wastes to pass through and beexcreted out of the Bowman's capsule as urine.

    The filtered blood passes out of theglomerulus into the efferent arteriole to bereturned through the medullary plexus to theintralobular vein.

  • 8/10/2019 sdr glomerular

    3/44

    3

    CLASIFICATION

    ACUTE NEPHRITIC SYNDROME

    RAPIDLY PROGRESSIVE

    GLOMERULONEPHRITIS NEPHROTIC SYNDROME

    ASYMPTOMATIC HEMATURIA ORPROTEINURIA

    CHRONIC GLOMERULONEPHRITIS

  • 8/10/2019 sdr glomerular

    4/44

    4

    ACUTE NEPHRITIC SYNDROME

    DEFINITION AND CLASIFICATION

    Acute nephritic syndrome is a group of disorders that causeinflammation of the internal kidney structures (specifically,the glomeruli), often caused by an immune responsetriggered by an infection or other disease.

    It is characterized by tissue swelling (edema), high blood

    pressure, the presence of red blood cells in the urine, redcell casts, proteinuria, renal failure.

    Nephritic syndrome can develop suddenly or over a shorttime period (acute nephritic syndrome) or develop andprogress slowly (chronic nephritic syndrome).

    In 1% of children and 10% of adults, the acute nephriticsyndrome evolves into rapidly progressiveglomerulonephritis, in which most of the glomeruli aredestroyed, resulting in kidney failure

  • 8/10/2019 sdr glomerular

    5/44

    5

    ETIOLOGY

    The cause of chronic nephritic syndromecannot be identified in many people.

    Often, chronic nephritic syndrome seems toresult from one of the same conditions thatcauses acute nephritic syndrome.

  • 8/10/2019 sdr glomerular

    6/44

    6

    PRIMARY GLOMERULOPATHIES

    ACUTE DIFFUSE PROLIFERATIVEGLOMERULONEPHRITIS

    RAPIDLY PROGRESSIVE (CRESCENTIC)GLOMERULONEPHRITIS

    MEMBRANOUS GLOMERULOPATHY

    MINIMAL CHANGE DISEASE

    FOCAL SEGMENTAL GLOMERULOSCLEROSIS

    MEMBRANOPROLIFERATIVEGLOMERULONEPHRITIS

    IgA NEPHROPATHY

    FOCAL PROLIFERATIVE GLOMERULONEPHRITIS

    FIBRILLARY GLOMERULOPATHY

  • 8/10/2019 sdr glomerular

    7/44

    7

    SYSTEMIC DISEASES

    SYSTEMIC LUPUS ERYTHEMATOSUS

    DIABETES MELLITUS

    AMYLOIDOSIS GOODPASTURE SYNDROME

    POLYARTERITIS NODOSA

    WEGENER GRANULOMATOSIS

    HENOCH-SCHONLEIN PURPURA

    BACTERIAL ENDOCARDITIS

  • 8/10/2019 sdr glomerular

    8/44

  • 8/10/2019 sdr glomerular

    9/44

    9

    HEREDITARY DISEASES

    ALPORT SYNDROME

    THIN MEMBRANE DISEASE

    FABRY DISEASE

  • 8/10/2019 sdr glomerular

    10/44

    10

    OTHERS

    Primary gravidic nephropathy

    Mixedema

    Dermatological diseases

    Obesity

  • 8/10/2019 sdr glomerular

    11/44

    11

    PATHOGENESIS

    ANTIBODY MEDIATED INJURY: Goodpasture antigen(anti-GBM nephritis)

    IN-SITU IMMUNE COMPLEX DEPOSITION Fixed intrinsic tissue antigens: Heymann antigen (membranous glomerulonephritis) Mesangial antigens Others Planted antigens:

    Exogenous (infections, drugs) Endogenous (DNA, immunoglobulins, immune

    complexes, IgA)

  • 8/10/2019 sdr glomerular

    12/44

    12

    CIRCULATING IMMUNE COMPLEX

    DEPOSITION

    CIRCULATING IMMUNE COMPLEXDEPOSITION

    Endogenous antigens (DNA, tumor antigens)

    Exogenous antigens (infectious products)

    CELL MEDIATED IMMUNE INJURY

    Rejet nephropathy

  • 8/10/2019 sdr glomerular

    13/44

    13

    SYMPTOMS

    Despite the diversity of diseases that cause acutenephritis below, they share many symptoms incommon.

    About half of the people with acute nephriticsyndrome have no symptoms.

    If symptoms do occur, the first to appear are fluidretention and tissue swelling (edema), low urinevolume, and dark urine that contains blood.

    Edema may first appear as puffiness of the face and

    eyelids but later is prominent in the legs.

  • 8/10/2019 sdr glomerular

    14/44

    14

    SYMPTOMS Blood pressure increases as kidney function becomes

    impaired. In turn, high blood pressure and swelling

    of the brain may produce headaches, visualdisturbances, and more serious disturbances of brainfunction.

    In older people, nonspecific symptoms, such asnausea and a general feeling of illness (malaise), aremore common.

    When rapidly progressive glomerulonephritisdevelops, weakness, fatigue, and fever are the mostobvious early symptoms. Loss of appetite, nausea,vomiting, abdominal pain, and joint pain are alsocommon.

    About 50% of people had a flu-like illness in themonth before kidney failure started to develop.These people have edema and usually produce verylittle urine. High blood pressure is uncommon andrarely severe when it does occur.

  • 8/10/2019 sdr glomerular

    15/44

    15

    SYMPTOMS

    Because chronic nephritic syndrome usually causesonly very mild or subtle symptoms for years, it goesundetected in most people.

    Fluid retention (edema) may occur. High blood pressure is common.

    The disease may progress to kidney failure, which cancause itchiness, fatigue, decreased appetite, nausea,

    vomiting, and difficulty breathing.

  • 8/10/2019 sdr glomerular

    16/44

    16

    SIGNS AND TESTS

    The blood pressure may be elevated.

    There may be signs of fluid overload (more fluid incirculation than the heart can effectively pump),

    including abnormal heart and lung sounds. Thejugular (neck) veins may be distended from increasedpressure.

    Generalized swelling is often present. When

    examining the abdomen, may be signs of fluidoverload and an enlarged liver.

    http://www.nlm.nih.gov/medlineplus/ency/article/003275.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003275.htm
  • 8/10/2019 sdr glomerular

    17/44

    17

    SIGNS AND TESTS

    There may be signs of acute kidney failureinaddition to the above symptoms.

    Urine appearance and colorare abnormal (coca-cola).

    Urinalysis nephritic urinary sediment revealsvariable number of red blood cells (RBCs), WBCs,and RBC casts (pathognomonic of activeglomerulonephritis)

    Protein in the urinetest is positive; Proteinuria is

    usually modest, ranging from 2 to 6 g in a 24-hourcollection

    http://www.nlm.nih.gov/medlineplus/ency/article/000501.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003580.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003580.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000501.htm
  • 8/10/2019 sdr glomerular

    18/44

    18

    SIGNS AND TESTS

    Azotemia (nitrogen-containing waste products in theblood) may be evidenced by: elevated BUN elevated creatinine

    potassium testmay be elevated.

    The creatinine clearancemay be decreased. kidney biopsy reveals glomerulonephritis

    (inflammation of the glomeruli), confirm thediagnosis, help determine the cause, and determinethe amount of scarring and potential for reversibility.

    A biopsy, however, is rarely performed in advanced

    stages, when the kidneys are shrunken and scarred,because the chance of obtaining specific informationabout the cause is small.

    http://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003474.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003475.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003484.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003611.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003907.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003611.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003484.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003475.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003474.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000508.htm
  • 8/10/2019 sdr glomerular

    19/44

    19

    SIGNS AND TESTS

    Tests for the cause of the acute nephriticsyndrome may include:

    Culture of the throator skin

    Blood culture

    ANAtiter (lupus) Serum complement(C3and C4)

    ANCA (antineutrophil cytoplasmic antibodyforvasculitis)

    Anti-glomerular basement membraneantibody

    http://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003746.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003744.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003535.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000435.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003456.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003539.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003354.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002223.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003524.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003524.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003524.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003524.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002223.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003354.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003539.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003456.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000435.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003535.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003744.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003746.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003746.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003579.htm
  • 8/10/2019 sdr glomerular

    20/44

    20

  • 8/10/2019 sdr glomerular

    21/44

    21

  • 8/10/2019 sdr glomerular

    22/44

    22

  • 8/10/2019 sdr glomerular

    23/44

    23

  • 8/10/2019 sdr glomerular

    24/44

    24

  • 8/10/2019 sdr glomerular

    25/44

    25

  • 8/10/2019 sdr glomerular

    26/44

    26

  • 8/10/2019 sdr glomerular

    27/44

    27

  • 8/10/2019 sdr glomerular

    28/44

    28

  • 8/10/2019 sdr glomerular

    29/44

    29

  • 8/10/2019 sdr glomerular

    30/44

    30

  • 8/10/2019 sdr glomerular

    31/44

    31

  • 8/10/2019 sdr glomerular

    32/44

    32

  • 8/10/2019 sdr glomerular

    33/44

    33

  • 8/10/2019 sdr glomerular

    34/44

    34

  • 8/10/2019 sdr glomerular

    35/44

    35

  • 8/10/2019 sdr glomerular

    36/44

    36

    Chronic Glomerulonephritis

    Chronic glomerulonephritis describes a patient withevidence of chronic renal failure who showscharacteristics of glomerular disease.

    The urinalysis demonstrates a few RBCs and WBCs but

    is mostly nonspecific. A variable amount of proteinuria is present. Kidney size is typically small, reflecting the presence

    of advanced fibrosis and glomerulosclerosis. Patientswith this syndrome presumably have a glomerulardisease that has progressed to end stage, leaving thekidneys irreversibly damaged.

    idl i

  • 8/10/2019 sdr glomerular

    37/44

    37

    Rapidly ProgressiveGlomerulonephritis

    Rapidly progressive glomerulonephritis should beconsidered in patients who present with a nephriticclinical picture and who have a nephritic urinarysediment.

    This condition is distinguished from acuteglomerulonephritis by the rapid loss of renal function,which is defined as a rise in the serum creatinineconcentration of more than 2 mg/dl over a 3-monthperiod.

    This syndrome has a much less consistent temporal

    relationship with infection, and there is little tendencyfor spontaneous recovery.

  • 8/10/2019 sdr glomerular

    38/44

    38

    Rapidly ProgressiveGlomerulonephritis

    This syndrome needs to be recognized early so thatrenal biopsy can be done and therapy institutedimmediately, if indicated.

    With patients in whom renal biopsy shows acrescentic glomerulonephritis, immunofluorescentstudies provide a useful classification of the diseasesthat most commonly give rise to this clinicalsyndrome.

  • 8/10/2019 sdr glomerular

    39/44

    39

    COMPLICATIONS

    Acute kidney failure Chronic kidney failure End-stage kidney disease High blood pressure Congestive heart failure Pulmonary edema Chronic glomerulonephritis

    Nephrotic syndrome

    http://www.nlm.nih.gov/medlineplus/ency/article/000501.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000471.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000500.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000468.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000158.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000140.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000499.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000490.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000490.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000499.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000140.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000158.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000468.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000500.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000500.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000500.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000471.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000501.htm
  • 8/10/2019 sdr glomerular

    40/44

    40

    PROGNOSIS

    Acute nephritic syndrome resolves completely inabout 80 to 90% of children and about 60% of adults.

    The prognosis for people with rapidly progressiveglomerulonephritis depends on the severity of

    glomerular scarring and whether the underlyingcause, such as infection, can be cured. In about half of the people who are treated early

    (within weeks to a few months), kidney function ispreserved and dialysis is not needed.

  • 8/10/2019 sdr glomerular

    41/44

    41

    PROGNOSIS

    However, because the early symptoms can be subtle

    and vague, many people who have rapidly progressiveglomerulonephritis are not aware of the underlyingdisease and do not seek medical care until kidneyfailure develops.

    People with advanced kidney failure die within a fewweeks unless they undergo dialysis.

    The prognosis also depends on the cause, the person'sage, and any other diseases the person might have.When the cause is unknown or the person is older, theprognosis is worse.

    In some children and adults who do not recover

    completely from acute nephritic syndrome, other typesof kidney disorders develop, such as asymptomaticproteinuria and hematuria syndrome or nephroticsyndrome.

    TREATMENT

  • 8/10/2019 sdr glomerular

    42/44

    42

    TREATMENT

    No specific treatment is available in most cases of

    acute nephritic syndrome. Following a diet that is low in protein and sodium may

    be necessary until kidney function recovers. Diuretics may be prescribed to help the kidneys

    excrete excess sodium and water.

    High blood pressure needs to be treated. When a bacterial infection is suspected as the cause of

    acute nephritic syndrome, antibiotics are usuallyineffective because the nephritis begins 1 to 6 weeks(average, 2 weeks) after the infection. However, if abacterial infection is still present when acute nephritic

    syndrome is discovered, antibiotic therapy is started.Antimalarial drugs may be beneficial if the cause of thesyndrome is malaria.

  • 8/10/2019 sdr glomerular

    43/44

    43

    TREATMENT

    For rapidly progressive glomerulonephritis, drugs tosuppress the immune system are started promptly.

    High doses of corticosteroids

    Cyclophosphamide

    plasmapheresis is sometimes used to removeantibodies from the blood

    dialysis

    Kidney transplantation is sometimes considered forpeople who have chronic kidney failure, but rapidly

    progressive glomerulonephritis may recur in thetransplanted kidney.

  • 8/10/2019 sdr glomerular

    44/44

    44

    TREATMENT

    For rapidly progressive glomerulonephritis, drugs tosuppress the immune system are started promptly.

    High doses of corticosteroids Cyclophosphamide plasmapheresis is sometimes used to remove

    antibodies from the blood dialysis Kidney transplantation is sometimes considered for

    people who have chronic kidney failure, but rapidlyprogressive glomerulonephritis may recur in the

    transplanted kidney. Angiotensin-converting enzyme (ACE) inhibitors often

    slow progression of chronic nephritic syndrome.